Primary Liver Cancer: Clinical Trials

5 trials for Primary Liver Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 terminated, 1 unknown. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 2, Completed 1, Terminated 1, Unknown 1

Follow Primary Liver Cancer: new trials by email Literature Review of Primary Liver Cancer trials Research Report on Primary Liver Cancer

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Y-90 Treatment Response Using Transarterial Radioembolization
Lumason, Sonazoid - HCC, Hepatocellular Carcinoma
Phase 2RecruitingThomas Jefferson University302025-09-112026-06-10
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Stereotactic Body Radiation Therapy (SBRT), Radiofrequency ablation therapy - Primary Liver Cancer
Phase 2RecruitingTianjin Medical University Cancer Institute and Hospital1302025-01-012025-01-09
RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial
Neo-MASCT - Primary Liver Cancer, Radiofrequency Ablation
Phase 2UnknownSun Yat-sen University982017-07-252022-01-26
Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation
Transarterialchemoembolisation (TACE), DC Bead with Doxorubicin - Primary Liver Cancer
Phase 2CompletedBoston Scientific Corporation2122005-11-012021-07-21
Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Antineoplaston therapy (Atengenal + Astugenal) - Primary Liver Cancer
Phase 2TerminatedBurzynski Research Institute31977-03-212017-11-21

Narrower conditions

Carcinoma, Hepatocellular (5)  ·  Carcinoma (1)  ·  Liver Neoplasms (1)

Broader conditions

Adenocarcinoma (5)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Liver Diseases (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms by Site (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Carcinoma (4)  ·  Liver Neoplasms (4)

Interventions

Radiosurgery (1)  ·  antineoplaston A10 (1)  ·  antineoplaston AS 2-1 (1)

Sponsors

Boston Scientific Corporation (1)  ·  Burzynski Research Institute (1)  ·  Sun Yat-sen University (1)  ·  Thomas Jefferson University (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)

Countries

China (2)  ·  United States (2)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Switzerland (1)

Top investigators

John Eisenbrey, PhD (1)  ·  Ming Kuang, Ph.D. (1)  ·  Prof Johannes Lammer (1)  ·  Stanislaw R. Burzynski, MD, PhD (1)

Results publications

PMID 21940527, PMID 35476700

NIH funding

R21CA303648 (1)